Personalized cancer vaccines are showing real clinical results, with melanoma patients on the mRNA-4157/pembrolizumab ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

Moderna, Inc. recently participated in the 5th LNP Formulation & Process Development Summit in Boston and scheduled a May 1, ...

CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...

The mRNA vaccine CDMO market is rapidly expanding, driven by growing biotech startups, limited in-house manufacturing, and ...

The FDA is reviewing the first mRNA flu vaccine for adults 50 and older. Learn how this technology could lead to faster and more effective shots.

The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...

A personalized mRNA vaccine shows breakthrough promise in pancreatic cancer, boosting survival up to six years by training ...

The Food and Drug Administration reversed course on Wednesday and agreed to formally review Moderna’s new flu vaccine that uses mRNA technology, the company announced in a news release. Earlier this ...

The Covid-19 shot may have further-reaching benefits than previously thought, as mRNA vaccines appear to help increase the effectiveness of immunotherapy in cancer patients. Widespread use of the ...

Bringing messenger RNA (mRNA) technology to the COVID-19 vaccine race means taking advantage of the platform’s flexible, scalable attributes, said a pharmaceutical executive, speaking at RAPS Euro ...

During the COVID-19 pandemic, President Donald Trump then described mRNA technology as a "modern-day miracle." HealthDay News — In a major blow to vaccine development, the US Food and Drug ...